Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
kai-1678 (3 trials)
ketorolac (acuvail) (1 trial)
lidocaine (xylocaine) (1 trial)
placulumab (1 trial)
lipovaxin (1 trial)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Melanoma (Phase 1)
Neuralgia (Phase 2)
Neuralgia, Postherpetic (Phase 2)
Pain, Postoperative (Phase 2)
Spinal Cord Injuries (Phase 2)
Wounds and Injuries (Phase 2)
Trials (5 total)
Trial APIs (5 total)